nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCB1—kidney cancer	0.147	1	CbGaD
Pitavastatin—SLCO2B1—Erlotinib—kidney cancer	0.056	0.0855	CbGbCtD
Pitavastatin—SLCO1B3—Paclitaxel—kidney cancer	0.0455	0.0695	CbGbCtD
Pitavastatin—SLCO1B1—Pazopanib—kidney cancer	0.0406	0.062	CbGbCtD
Pitavastatin—ORM1—Erlotinib—kidney cancer	0.0377	0.0576	CbGbCtD
Pitavastatin—ABCG2—Pazopanib—kidney cancer	0.0323	0.0492	CbGbCtD
Pitavastatin—ABCG2—Dactinomycin—kidney cancer	0.0295	0.045	CbGbCtD
Pitavastatin—ABCC2—Paclitaxel—kidney cancer	0.0233	0.0356	CbGbCtD
Pitavastatin—ABCG2—Erlotinib—kidney cancer	0.023	0.0351	CbGbCtD
Pitavastatin—ABCB1—Temsirolimus—kidney cancer	0.0221	0.0338	CbGbCtD
Pitavastatin—ABCG2—Paclitaxel—kidney cancer	0.0211	0.0322	CbGbCtD
Pitavastatin—ABCC2—Sorafenib—kidney cancer	0.0207	0.0316	CbGbCtD
Pitavastatin—ABCC2—Vinblastine—kidney cancer	0.0204	0.0312	CbGbCtD
Pitavastatin—ABCC2—Vincristine—kidney cancer	0.0201	0.0307	CbGbCtD
Pitavastatin—ABCG2—Sorafenib—kidney cancer	0.0187	0.0286	CbGbCtD
Pitavastatin—ABCG2—Vincristine—kidney cancer	0.0182	0.0277	CbGbCtD
Pitavastatin—CYP2C8—Pazopanib—kidney cancer	0.0172	0.0262	CbGbCtD
Pitavastatin—ABCC2—Sunitinib—kidney cancer	0.0168	0.0256	CbGbCtD
Pitavastatin—ALB—Erlotinib—kidney cancer	0.0159	0.0242	CbGbCtD
Pitavastatin—ABCG2—Sunitinib—kidney cancer	0.0152	0.0231	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—kidney cancer	0.0126	0.0192	CbGbCtD
Pitavastatin—CYP2C9—Capecitabine—kidney cancer	0.0125	0.0191	CbGbCtD
Pitavastatin—CYP2C8—Erlotinib—kidney cancer	0.0123	0.0187	CbGbCtD
Pitavastatin—ABCB1—Pazopanib—kidney cancer	0.0116	0.0178	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—kidney cancer	0.0114	0.0173	CbGbCtD
Pitavastatin—CYP2C8—Paclitaxel—kidney cancer	0.0112	0.0171	CbGbCtD
Pitavastatin—ABCB1—Dactinomycin—kidney cancer	0.0106	0.0162	CbGbCtD
Pitavastatin—CYP2C8—Sorafenib—kidney cancer	0.00997	0.0152	CbGbCtD
Pitavastatin—ABCB1—Gemcitabine—kidney cancer	0.00841	0.0128	CbGbCtD
Pitavastatin—ABCB1—Erlotinib—kidney cancer	0.0083	0.0127	CbGbCtD
Pitavastatin—CYP2C9—Paclitaxel—kidney cancer	0.00783	0.012	CbGbCtD
Pitavastatin—ABCB1—Paclitaxel—kidney cancer	0.0076	0.0116	CbGbCtD
Pitavastatin—CYP2C9—Sorafenib—kidney cancer	0.00695	0.0106	CbGbCtD
Pitavastatin—ABCB1—Sorafenib—kidney cancer	0.00675	0.0103	CbGbCtD
Pitavastatin—ABCB1—Vinblastine—kidney cancer	0.00666	0.0102	CbGbCtD
Pitavastatin—ABCB1—Vincristine—kidney cancer	0.00655	0.01	CbGbCtD
Pitavastatin—ABCB1—Sunitinib—kidney cancer	0.00547	0.00835	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—kidney cancer	0.00409	0.00625	CbGbCtD
Pitavastatin—CYP2C9—urine—kidney cancer	0.00179	0.0825	CbGeAlD
Pitavastatin—SLC10A1—renal system—kidney cancer	0.00131	0.0603	CbGeAlD
Pitavastatin—SLC10A1—kidney—kidney cancer	0.00127	0.0583	CbGeAlD
Pitavastatin—UGT2B7—renal system—kidney cancer	0.00123	0.0565	CbGeAlD
Pitavastatin—UGT2B7—kidney—kidney cancer	0.00119	0.0546	CbGeAlD
Pitavastatin—SLC10A1—gonad—kidney cancer	0.00117	0.054	CbGeAlD
Pitavastatin—HMGCR—nephron tubule—kidney cancer	0.000997	0.0459	CbGeAlD
Pitavastatin—HMGCR—renal system—kidney cancer	0.000906	0.0417	CbGeAlD
Pitavastatin—HMGCR—kidney—kidney cancer	0.000876	0.0403	CbGeAlD
Pitavastatin—SLCO1B1—renal system—kidney cancer	0.000868	0.04	CbGeAlD
Pitavastatin—HMGCR—cortex of kidney—kidney cancer	0.000853	0.0393	CbGeAlD
Pitavastatin—SLCO1B1—kidney—kidney cancer	0.000839	0.0386	CbGeAlD
Pitavastatin—HMGCR—gonad—kidney cancer	0.000813	0.0374	CbGeAlD
Pitavastatin—HMGCR—cardiac atrium—kidney cancer	0.000812	0.0374	CbGeAlD
Pitavastatin—SLCO2B1—renal system—kidney cancer	0.000768	0.0353	CbGeAlD
Pitavastatin—SLCO2B1—kidney—kidney cancer	0.000742	0.0342	CbGeAlD
Pitavastatin—ABCC2—nephron tubule—kidney cancer	0.000724	0.0333	CbGeAlD
Pitavastatin—Fluvastatin—CYP1A1—kidney cancer	0.000659	0.683	CrCbGaD
Pitavastatin—ABCC2—renal system—kidney cancer	0.000658	0.0303	CbGeAlD
Pitavastatin—ABCC2—kidney—kidney cancer	0.000636	0.0293	CbGeAlD
Pitavastatin—ABCC2—cortex of kidney—kidney cancer	0.00062	0.0285	CbGeAlD
Pitavastatin—ABCG2—nephron tubule—kidney cancer	0.000528	0.0243	CbGeAlD
Pitavastatin—CYP2C8—renal system—kidney cancer	0.000494	0.0227	CbGeAlD
Pitavastatin—CYP2C8—kidney—kidney cancer	0.000477	0.022	CbGeAlD
Pitavastatin—Discomfort—Vinblastine—kidney cancer	0.00039	0.00345	CcSEcCtD
Pitavastatin—Discomfort—Everolimus—kidney cancer	0.000388	0.00344	CcSEcCtD
Pitavastatin—Muscle spasms—Sorafenib—kidney cancer	0.000385	0.00341	CcSEcCtD
Pitavastatin—Nasopharyngitis—Paclitaxel—kidney cancer	0.000385	0.0034	CcSEcCtD
Pitavastatin—Renal failure acute—Capecitabine—kidney cancer	0.000382	0.00338	CcSEcCtD
Pitavastatin—Arthralgia—Erlotinib—kidney cancer	0.000379	0.00336	CcSEcCtD
Pitavastatin—Myalgia—Erlotinib—kidney cancer	0.000379	0.00336	CcSEcCtD
Pitavastatin—Abdominal pain—Pazopanib—kidney cancer	0.000377	0.00334	CcSEcCtD
Pitavastatin—Amnesia—Capecitabine—kidney cancer	0.000376	0.00332	CcSEcCtD
Pitavastatin—Hypersensitivity—Temsirolimus—kidney cancer	0.000373	0.0033	CcSEcCtD
Pitavastatin—Back pain—Sunitinib—kidney cancer	0.000373	0.0033	CcSEcCtD
Pitavastatin—Hypoaesthesia—Vincristine—kidney cancer	0.000373	0.0033	CcSEcCtD
Pitavastatin—Influenza—Paclitaxel—kidney cancer	0.000372	0.00329	CcSEcCtD
Pitavastatin—Muscle spasms—Sunitinib—kidney cancer	0.000371	0.00328	CcSEcCtD
Pitavastatin—Asthenia—Temsirolimus—kidney cancer	0.000363	0.00322	CcSEcCtD
Pitavastatin—Pruritus—Temsirolimus—kidney cancer	0.000358	0.00317	CcSEcCtD
Pitavastatin—Pain in extremity—Capecitabine—kidney cancer	0.000353	0.00312	CcSEcCtD
Pitavastatin—Diarrhoea—Temsirolimus—kidney cancer	0.000347	0.00307	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000343	0.00304	CcSEcCtD
Pitavastatin—Asthenia—Pazopanib—kidney cancer	0.000342	0.00303	CcSEcCtD
Pitavastatin—Myalgia—Sorafenib—kidney cancer	0.000341	0.00302	CcSEcCtD
Pitavastatin—Arthralgia—Sorafenib—kidney cancer	0.000341	0.00302	CcSEcCtD
Pitavastatin—Insomnia—Everolimus—kidney cancer	0.000341	0.00302	CcSEcCtD
Pitavastatin—Ill-defined disorder—Dactinomycin—kidney cancer	0.000339	0.003	CcSEcCtD
Pitavastatin—Pruritus—Pazopanib—kidney cancer	0.000338	0.00299	CcSEcCtD
Pitavastatin—Dizziness—Temsirolimus—kidney cancer	0.000335	0.00296	CcSEcCtD
Pitavastatin—Dyspepsia—Everolimus—kidney cancer	0.000332	0.00293	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000331	0.00293	CcSEcCtD
Pitavastatin—Malaise—Dactinomycin—kidney cancer	0.000329	0.00291	CcSEcCtD
Pitavastatin—Insomnia—Erlotinib—kidney cancer	0.000329	0.00291	CcSEcCtD
Pitavastatin—Myalgia—Sunitinib—kidney cancer	0.000328	0.0029	CcSEcCtD
Pitavastatin—Arthralgia—Sunitinib—kidney cancer	0.000328	0.0029	CcSEcCtD
Pitavastatin—Diarrhoea—Pazopanib—kidney cancer	0.000327	0.00289	CcSEcCtD
Pitavastatin—Fatigue—Everolimus—kidney cancer	0.000325	0.00287	CcSEcCtD
Pitavastatin—Constipation—Vinblastine—kidney cancer	0.000323	0.00286	CcSEcCtD
Pitavastatin—Constipation—Everolimus—kidney cancer	0.000322	0.00285	CcSEcCtD
Pitavastatin—Dyspepsia—Erlotinib—kidney cancer	0.00032	0.00283	CcSEcCtD
Pitavastatin—Rash—Temsirolimus—kidney cancer	0.000319	0.00283	CcSEcCtD
Pitavastatin—Dermatitis—Temsirolimus—kidney cancer	0.000319	0.00282	CcSEcCtD
Pitavastatin—Headache—Temsirolimus—kidney cancer	0.000317	0.00281	CcSEcCtD
Pitavastatin—Nasopharyngitis—Capecitabine—kidney cancer	0.000316	0.00279	CcSEcCtD
Pitavastatin—Dizziness—Pazopanib—kidney cancer	0.000316	0.00279	CcSEcCtD
Pitavastatin—Back pain—Vincristine—kidney cancer	0.000316	0.00279	CcSEcCtD
Pitavastatin—Fatigue—Erlotinib—kidney cancer	0.000313	0.00277	CcSEcCtD
Pitavastatin—Feeling abnormal—Vinblastine—kidney cancer	0.000312	0.00276	CcSEcCtD
Pitavastatin—Constipation—Erlotinib—kidney cancer	0.000311	0.00275	CcSEcCtD
Pitavastatin—Myalgia—Dactinomycin—kidney cancer	0.000311	0.00275	CcSEcCtD
Pitavastatin—Feeling abnormal—Everolimus—kidney cancer	0.000311	0.00275	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vinblastine—kidney cancer	0.000309	0.00274	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Everolimus—kidney cancer	0.000308	0.00273	CcSEcCtD
Pitavastatin—Discomfort—Dactinomycin—kidney cancer	0.000307	0.00272	CcSEcCtD
Pitavastatin—Influenza—Capecitabine—kidney cancer	0.000305	0.0027	CcSEcCtD
Pitavastatin—Atorvastatin—ABCB1—kidney cancer	0.000305	0.316	CrCbGaD
Pitavastatin—Rash—Pazopanib—kidney cancer	0.000301	0.00266	CcSEcCtD
Pitavastatin—Nausea—Temsirolimus—kidney cancer	0.000301	0.00266	CcSEcCtD
Pitavastatin—Dermatitis—Pazopanib—kidney cancer	0.000301	0.00266	CcSEcCtD
Pitavastatin—Back pain—Gemcitabine—kidney cancer	0.000299	0.00265	CcSEcCtD
Pitavastatin—Abdominal pain—Vinblastine—kidney cancer	0.000299	0.00265	CcSEcCtD
Pitavastatin—Headache—Pazopanib—kidney cancer	0.000299	0.00264	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000298	0.00264	CcSEcCtD
Pitavastatin—Abdominal pain—Everolimus—kidney cancer	0.000298	0.00264	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Erlotinib—kidney cancer	0.000297	0.00263	CcSEcCtD
Pitavastatin—Hypoaesthesia—Paclitaxel—kidney cancer	0.000296	0.00262	CcSEcCtD
Pitavastatin—Abdominal discomfort—Capecitabine—kidney cancer	0.000293	0.00259	CcSEcCtD
Pitavastatin—Dyspepsia—Sorafenib—kidney cancer	0.000288	0.00255	CcSEcCtD
Pitavastatin—Abdominal pain—Erlotinib—kidney cancer	0.000287	0.00254	CcSEcCtD
Pitavastatin—Ill-defined disorder—Gemcitabine—kidney cancer	0.000287	0.00254	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000287	0.00254	CcSEcCtD
Pitavastatin—Insomnia—Sunitinib—kidney cancer	0.000285	0.00252	CcSEcCtD
Pitavastatin—Nausea—Pazopanib—kidney cancer	0.000283	0.00251	CcSEcCtD
Pitavastatin—Fatigue—Sorafenib—kidney cancer	0.000282	0.00249	CcSEcCtD
Pitavastatin—Constipation—Sorafenib—kidney cancer	0.00028	0.00247	CcSEcCtD
Pitavastatin—Malaise—Gemcitabine—kidney cancer	0.000279	0.00247	CcSEcCtD
Pitavastatin—Hypersensitivity—Vinblastine—kidney cancer	0.000279	0.00247	CcSEcCtD
Pitavastatin—Myalgia—Vincristine—kidney cancer	0.000278	0.00246	CcSEcCtD
Pitavastatin—Hypersensitivity—Everolimus—kidney cancer	0.000278	0.00246	CcSEcCtD
Pitavastatin—Dyspepsia—Sunitinib—kidney cancer	0.000277	0.00245	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000271	0.0024	CcSEcCtD
Pitavastatin—Asthenia—Vinblastine—kidney cancer	0.000271	0.0024	CcSEcCtD
Pitavastatin—Fatigue—Sunitinib—kidney cancer	0.000271	0.0024	CcSEcCtD
Pitavastatin—Asthenia—Everolimus—kidney cancer	0.00027	0.00239	CcSEcCtD
Pitavastatin—Constipation—Sunitinib—kidney cancer	0.000269	0.00238	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000267	0.00237	CcSEcCtD
Pitavastatin—Pruritus—Everolimus—kidney cancer	0.000267	0.00236	CcSEcCtD
Pitavastatin—Jaundice—Capecitabine—kidney cancer	0.000265	0.00235	CcSEcCtD
Pitavastatin—Myalgia—Gemcitabine—kidney cancer	0.000263	0.00233	CcSEcCtD
Pitavastatin—Arthralgia—Gemcitabine—kidney cancer	0.000263	0.00233	CcSEcCtD
Pitavastatin—Asthenia—Erlotinib—kidney cancer	0.000261	0.00231	CcSEcCtD
Pitavastatin—ABCB1—nephron tubule—kidney cancer	0.00026	0.012	CbGeAlD
Pitavastatin—Discomfort—Gemcitabine—kidney cancer	0.00026	0.0023	CcSEcCtD
Pitavastatin—Urticaria—Sorafenib—kidney cancer	0.00026	0.0023	CcSEcCtD
Pitavastatin—Diarrhoea—Vinblastine—kidney cancer	0.000259	0.00229	CcSEcCtD
Pitavastatin—Abdominal pain—Sorafenib—kidney cancer	0.000259	0.00229	CcSEcCtD
Pitavastatin—Diarrhoea—Everolimus—kidney cancer	0.000258	0.00228	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000257	0.00228	CcSEcCtD
Pitavastatin—Pruritus—Erlotinib—kidney cancer	0.000257	0.00228	CcSEcCtD
Pitavastatin—Fatigue—Dactinomycin—kidney cancer	0.000257	0.00227	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—kidney cancer	0.000253	0.00224	CcSEcCtD
Pitavastatin—Back pain—Paclitaxel—kidney cancer	0.000251	0.00222	CcSEcCtD
Pitavastatin—Dizziness—Vinblastine—kidney cancer	0.00025	0.00221	CcSEcCtD
Pitavastatin—Dizziness—Everolimus—kidney cancer	0.000249	0.0022	CcSEcCtD
Pitavastatin—Muscle spasms—Paclitaxel—kidney cancer	0.000249	0.0022	CcSEcCtD
Pitavastatin—Abdominal pain—Sunitinib—kidney cancer	0.000249	0.0022	CcSEcCtD
Pitavastatin—Diarrhoea—Erlotinib—kidney cancer	0.000249	0.0022	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—kidney cancer	0.000246	0.00218	CcSEcCtD
Pitavastatin—Feeling abnormal—Dactinomycin—kidney cancer	0.000246	0.00217	CcSEcCtD
Pitavastatin—Hepatitis—Capecitabine—kidney cancer	0.000244	0.00216	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000244	0.00216	CcSEcCtD
Pitavastatin—Hypoaesthesia—Capecitabine—kidney cancer	0.000243	0.00215	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000243	0.00215	CcSEcCtD
Pitavastatin—Hypersensitivity—Sorafenib—kidney cancer	0.000241	0.00213	CcSEcCtD
Pitavastatin—Insomnia—Vincristine—kidney cancer	0.000241	0.00213	CcSEcCtD
Pitavastatin—Dizziness—Erlotinib—kidney cancer	0.00024	0.00213	CcSEcCtD
Pitavastatin—Ill-defined disorder—Paclitaxel—kidney cancer	0.00024	0.00213	CcSEcCtD
Pitavastatin—Rash—Everolimus—kidney cancer	0.000238	0.0021	CcSEcCtD
Pitavastatin—Dermatitis—Everolimus—kidney cancer	0.000237	0.0021	CcSEcCtD
Pitavastatin—Headache—Vinblastine—kidney cancer	0.000237	0.0021	CcSEcCtD
Pitavastatin—ABCB1—renal system—kidney cancer	0.000237	0.0109	CbGeAlD
Pitavastatin—Headache—Everolimus—kidney cancer	0.000236	0.00209	CcSEcCtD
Pitavastatin—Abdominal pain—Dactinomycin—kidney cancer	0.000236	0.00208	CcSEcCtD
Pitavastatin—Asthenia—Sorafenib—kidney cancer	0.000235	0.00208	CcSEcCtD
Pitavastatin—Malaise—Paclitaxel—kidney cancer	0.000234	0.00207	CcSEcCtD
Pitavastatin—Hypersensitivity—Sunitinib—kidney cancer	0.000232	0.00205	CcSEcCtD
Pitavastatin—Pruritus—Sorafenib—kidney cancer	0.000231	0.00205	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00023	0.00204	CcSEcCtD
Pitavastatin—Fatigue—Vincristine—kidney cancer	0.00023	0.00203	CcSEcCtD
Pitavastatin—Rash—Erlotinib—kidney cancer	0.000229	0.00203	CcSEcCtD
Pitavastatin—Dermatitis—Erlotinib—kidney cancer	0.000229	0.00203	CcSEcCtD
Pitavastatin—ABCB1—kidney—kidney cancer	0.000229	0.0105	CbGeAlD
Pitavastatin—Insomnia—Gemcitabine—kidney cancer	0.000228	0.00202	CcSEcCtD
Pitavastatin—Headache—Erlotinib—kidney cancer	0.000228	0.00202	CcSEcCtD
Pitavastatin—Constipation—Vincristine—kidney cancer	0.000228	0.00201	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—kidney cancer	0.000228	0.00201	CcSEcCtD
Pitavastatin—Asthenia—Sunitinib—kidney cancer	0.000226	0.002	CcSEcCtD
Pitavastatin—Nausea—Vinblastine—kidney cancer	0.000225	0.00199	CcSEcCtD
Pitavastatin—Nausea—Everolimus—kidney cancer	0.000224	0.00198	CcSEcCtD
Pitavastatin—Diarrhoea—Sorafenib—kidney cancer	0.000224	0.00198	CcSEcCtD
Pitavastatin—ABCB1—cortex of kidney—kidney cancer	0.000223	0.0103	CbGeAlD
Pitavastatin—Pruritus—Sunitinib—kidney cancer	0.000223	0.00197	CcSEcCtD
Pitavastatin—Arthralgia—Paclitaxel—kidney cancer	0.000221	0.00195	CcSEcCtD
Pitavastatin—Myalgia—Paclitaxel—kidney cancer	0.000221	0.00195	CcSEcCtD
Pitavastatin—Hypersensitivity—Dactinomycin—kidney cancer	0.00022	0.00194	CcSEcCtD
Pitavastatin—Discomfort—Paclitaxel—kidney cancer	0.000218	0.00193	CcSEcCtD
Pitavastatin—Fatigue—Gemcitabine—kidney cancer	0.000218	0.00193	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vincristine—kidney cancer	0.000218	0.00193	CcSEcCtD
Pitavastatin—Dizziness—Sorafenib—kidney cancer	0.000216	0.00191	CcSEcCtD
Pitavastatin—Constipation—Gemcitabine—kidney cancer	0.000216	0.00191	CcSEcCtD
Pitavastatin—Nausea—Erlotinib—kidney cancer	0.000216	0.00191	CcSEcCtD
Pitavastatin—Diarrhoea—Sunitinib—kidney cancer	0.000215	0.00191	CcSEcCtD
Pitavastatin—Asthenia—Dactinomycin—kidney cancer	0.000214	0.00189	CcSEcCtD
Pitavastatin—Confusional state—Paclitaxel—kidney cancer	0.000213	0.00189	CcSEcCtD
Pitavastatin—ABCB1—gonad—kidney cancer	0.000212	0.00977	CbGeAlD
Pitavastatin—Abdominal pain—Vincristine—kidney cancer	0.00021	0.00186	CcSEcCtD
Pitavastatin—Dizziness—Sunitinib—kidney cancer	0.000208	0.00184	CcSEcCtD
Pitavastatin—Feeling abnormal—Gemcitabine—kidney cancer	0.000208	0.00184	CcSEcCtD
Pitavastatin—Rash—Sorafenib—kidney cancer	0.000206	0.00182	CcSEcCtD
Pitavastatin—Dermatitis—Sorafenib—kidney cancer	0.000206	0.00182	CcSEcCtD
Pitavastatin—Back pain—Capecitabine—kidney cancer	0.000206	0.00182	CcSEcCtD
Pitavastatin—Headache—Sorafenib—kidney cancer	0.000205	0.00181	CcSEcCtD
Pitavastatin—Muscle spasms—Capecitabine—kidney cancer	0.000204	0.00181	CcSEcCtD
Pitavastatin—Diarrhoea—Dactinomycin—kidney cancer	0.000204	0.0018	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000204	0.0018	CcSEcCtD
Pitavastatin—Rash—Sunitinib—kidney cancer	0.000198	0.00176	CcSEcCtD
Pitavastatin—Dermatitis—Sunitinib—kidney cancer	0.000198	0.00175	CcSEcCtD
Pitavastatin—Ill-defined disorder—Capecitabine—kidney cancer	0.000197	0.00175	CcSEcCtD
Pitavastatin—Headache—Sunitinib—kidney cancer	0.000197	0.00174	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—kidney cancer	0.000197	0.00174	CcSEcCtD
Pitavastatin—Hypersensitivity—Vincristine—kidney cancer	0.000196	0.00174	CcSEcCtD
Pitavastatin—Nausea—Sorafenib—kidney cancer	0.000194	0.00172	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000193	0.0017	CcSEcCtD
Pitavastatin—Malaise—Capecitabine—kidney cancer	0.000192	0.0017	CcSEcCtD
Pitavastatin—Insomnia—Paclitaxel—kidney cancer	0.000191	0.00169	CcSEcCtD
Pitavastatin—Asthenia—Vincristine—kidney cancer	0.000191	0.00169	CcSEcCtD
Pitavastatin—Rash—Dactinomycin—kidney cancer	0.000188	0.00166	CcSEcCtD
Pitavastatin—Nausea—Sunitinib—kidney cancer	0.000187	0.00165	CcSEcCtD
Pitavastatin—Dyspepsia—Paclitaxel—kidney cancer	0.000186	0.00165	CcSEcCtD
Pitavastatin—Fatigue—Paclitaxel—kidney cancer	0.000182	0.00161	CcSEcCtD
Pitavastatin—Diarrhoea—Vincristine—kidney cancer	0.000182	0.00161	CcSEcCtD
Pitavastatin—Asthenia—Gemcitabine—kidney cancer	0.000181	0.0016	CcSEcCtD
Pitavastatin—Arthralgia—Capecitabine—kidney cancer	0.000181	0.0016	CcSEcCtD
Pitavastatin—Myalgia—Capecitabine—kidney cancer	0.000181	0.0016	CcSEcCtD
Pitavastatin—Constipation—Paclitaxel—kidney cancer	0.000181	0.0016	CcSEcCtD
Pitavastatin—Discomfort—Capecitabine—kidney cancer	0.000179	0.00158	CcSEcCtD
Pitavastatin—Pruritus—Gemcitabine—kidney cancer	0.000179	0.00158	CcSEcCtD
Pitavastatin—Nausea—Dactinomycin—kidney cancer	0.000177	0.00157	CcSEcCtD
Pitavastatin—Dizziness—Vincristine—kidney cancer	0.000176	0.00156	CcSEcCtD
Pitavastatin—Confusional state—Capecitabine—kidney cancer	0.000175	0.00155	CcSEcCtD
Pitavastatin—Feeling abnormal—Paclitaxel—kidney cancer	0.000174	0.00154	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000173	0.00153	CcSEcCtD
Pitavastatin—Diarrhoea—Gemcitabine—kidney cancer	0.000173	0.00153	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—kidney cancer	0.000171	0.00151	CcSEcCtD
Pitavastatin—Urticaria—Paclitaxel—kidney cancer	0.000168	0.00149	CcSEcCtD
Pitavastatin—Rash—Vincristine—kidney cancer	0.000168	0.00148	CcSEcCtD
Pitavastatin—Dermatitis—Vincristine—kidney cancer	0.000168	0.00148	CcSEcCtD
Pitavastatin—Abdominal pain—Paclitaxel—kidney cancer	0.000167	0.00148	CcSEcCtD
Pitavastatin—Headache—Vincristine—kidney cancer	0.000167	0.00148	CcSEcCtD
Pitavastatin—Rash—Gemcitabine—kidney cancer	0.000159	0.00141	CcSEcCtD
Pitavastatin—Dermatitis—Gemcitabine—kidney cancer	0.000159	0.00141	CcSEcCtD
Pitavastatin—Headache—Gemcitabine—kidney cancer	0.000158	0.0014	CcSEcCtD
Pitavastatin—Nausea—Vincristine—kidney cancer	0.000158	0.0014	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000158	0.0014	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—kidney cancer	0.000157	0.00139	CcSEcCtD
Pitavastatin—Insomnia—Capecitabine—kidney cancer	0.000157	0.00139	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000157	0.00139	CcSEcCtD
Pitavastatin—Hypersensitivity—Paclitaxel—kidney cancer	0.000156	0.00138	CcSEcCtD
Pitavastatin—Dyspepsia—Capecitabine—kidney cancer	0.000153	0.00135	CcSEcCtD
Pitavastatin—Asthenia—Paclitaxel—kidney cancer	0.000152	0.00134	CcSEcCtD
Pitavastatin—Nausea—Gemcitabine—kidney cancer	0.00015	0.00133	CcSEcCtD
Pitavastatin—Fatigue—Capecitabine—kidney cancer	0.00015	0.00132	CcSEcCtD
Pitavastatin—Pruritus—Paclitaxel—kidney cancer	0.00015	0.00132	CcSEcCtD
Pitavastatin—Constipation—Capecitabine—kidney cancer	0.000148	0.00131	CcSEcCtD
Pitavastatin—Diarrhoea—Paclitaxel—kidney cancer	0.000145	0.00128	CcSEcCtD
Pitavastatin—Feeling abnormal—Capecitabine—kidney cancer	0.000143	0.00127	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000142	0.00126	CcSEcCtD
Pitavastatin—Dizziness—Paclitaxel—kidney cancer	0.00014	0.00124	CcSEcCtD
Pitavastatin—Urticaria—Capecitabine—kidney cancer	0.000138	0.00122	CcSEcCtD
Pitavastatin—Abdominal pain—Capecitabine—kidney cancer	0.000137	0.00121	CcSEcCtD
Pitavastatin—Rash—Paclitaxel—kidney cancer	0.000133	0.00118	CcSEcCtD
Pitavastatin—Dermatitis—Paclitaxel—kidney cancer	0.000133	0.00118	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—kidney cancer	0.000133	0.00117	CcSEcCtD
Pitavastatin—Headache—Paclitaxel—kidney cancer	0.000132	0.00117	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—kidney cancer	0.000132	0.00117	CcSEcCtD
Pitavastatin—Hypersensitivity—Capecitabine—kidney cancer	0.000128	0.00113	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000127	0.00112	CcSEcCtD
Pitavastatin—Nausea—Paclitaxel—kidney cancer	0.000126	0.00111	CcSEcCtD
Pitavastatin—Asthenia—Capecitabine—kidney cancer	0.000124	0.0011	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—kidney cancer	0.000124	0.00109	CcSEcCtD
Pitavastatin—Pruritus—Capecitabine—kidney cancer	0.000123	0.00109	CcSEcCtD
Pitavastatin—Diarrhoea—Capecitabine—kidney cancer	0.000119	0.00105	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—kidney cancer	0.000117	0.00103	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—kidney cancer	0.000117	0.00103	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—kidney cancer	0.000115	0.00102	CcSEcCtD
Pitavastatin—Dizziness—Capecitabine—kidney cancer	0.000115	0.00102	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—kidney cancer	0.000113	0.000998	CcSEcCtD
Pitavastatin—Rash—Capecitabine—kidney cancer	0.000109	0.000968	CcSEcCtD
Pitavastatin—Dermatitis—Capecitabine—kidney cancer	0.000109	0.000967	CcSEcCtD
Pitavastatin—Headache—Capecitabine—kidney cancer	0.000109	0.000962	CcSEcCtD
Pitavastatin—Nausea—Capecitabine—kidney cancer	0.000103	0.000912	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000102	0.000902	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—kidney cancer	0.000101	0.000895	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—kidney cancer	9.85e-05	0.000871	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—kidney cancer	9.64e-05	0.000853	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—kidney cancer	9.56e-05	0.000846	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—kidney cancer	9.22e-05	0.000815	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—kidney cancer	9.15e-05	0.000809	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—kidney cancer	8.89e-05	0.000786	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—kidney cancer	8.84e-05	0.000782	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—kidney cancer	8.24e-05	0.000729	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—kidney cancer	8.03e-05	0.00071	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—kidney cancer	7.91e-05	0.0007	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—kidney cancer	7.65e-05	0.000677	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—kidney cancer	7.4e-05	0.000654	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—kidney cancer	7.05e-05	0.000624	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—kidney cancer	7.05e-05	0.000623	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—kidney cancer	7.01e-05	0.00062	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—kidney cancer	6.64e-05	0.000588	CcSEcCtD
Pitavastatin—UGT2B7—Metabolism—SLC2A1—kidney cancer	1.74e-05	0.000278	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ITPR2—kidney cancer	1.71e-05	0.000273	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTP1—kidney cancer	1.71e-05	0.000272	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CRABP1—kidney cancer	1.7e-05	0.000272	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPC3—kidney cancer	1.68e-05	0.000269	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GLIPR1—kidney cancer	1.68e-05	0.000268	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPAT—kidney cancer	1.68e-05	0.000268	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPC3—kidney cancer	1.67e-05	0.000268	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—POMC—kidney cancer	1.67e-05	0.000266	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IFNA2—kidney cancer	1.64e-05	0.000263	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CA2—kidney cancer	1.64e-05	0.000262	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.64e-05	0.000261	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.64e-05	0.000261	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.63e-05	0.00026	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CA2—kidney cancer	1.63e-05	0.00026	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ABCB1—kidney cancer	1.61e-05	0.000258	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTP1—kidney cancer	1.61e-05	0.000257	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALAD—kidney cancer	1.6e-05	0.000255	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALAD—kidney cancer	1.59e-05	0.000254	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ITPR2—kidney cancer	1.58e-05	0.000253	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.58e-05	0.000253	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.58e-05	0.000252	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.57e-05	0.000252	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.57e-05	0.000251	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPAT—kidney cancer	1.57e-05	0.000251	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTM1—kidney cancer	1.57e-05	0.00025	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APRT—kidney cancer	1.56e-05	0.000249	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—FH—kidney cancer	1.56e-05	0.000249	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.56e-05	0.000249	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ACHE—kidney cancer	1.56e-05	0.000249	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.56e-05	0.000249	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.56e-05	0.000249	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ST3GAL2—kidney cancer	1.55e-05	0.000248	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.55e-05	0.000247	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.54e-05	0.000246	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.53e-05	0.000245	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.52e-05	0.000243	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ABCB1—kidney cancer	1.52e-05	0.000243	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ALDH1A1—kidney cancer	1.51e-05	0.000242	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.51e-05	0.000241	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.5e-05	0.000239	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP1A1—kidney cancer	1.49e-05	0.000237	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IGF2—kidney cancer	1.48e-05	0.000237	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTM1—kidney cancer	1.48e-05	0.000236	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.47e-05	0.000236	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPC3—kidney cancer	1.47e-05	0.000234	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.46e-05	0.000233	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PGK1—kidney cancer	1.46e-05	0.000233	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.46e-05	0.000233	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APRT—kidney cancer	1.46e-05	0.000233	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—FH—kidney cancer	1.46e-05	0.000233	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PGK1—kidney cancer	1.45e-05	0.000232	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC5A3—kidney cancer	1.45e-05	0.000232	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTP1—kidney cancer	1.45e-05	0.000232	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ACHE—kidney cancer	1.44e-05	0.00023	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTT1—kidney cancer	1.44e-05	0.00023	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.43e-05	0.000229	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LDHB—kidney cancer	1.43e-05	0.000229	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.43e-05	0.000229	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CA2—kidney cancer	1.43e-05	0.000228	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.43e-05	0.000228	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.43e-05	0.000228	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LDHB—kidney cancer	1.42e-05	0.000227	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.42e-05	0.000226	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP1A1—kidney cancer	1.4e-05	0.000224	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALAD—kidney cancer	1.39e-05	0.000222	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.38e-05	0.000221	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ABCB1—kidney cancer	1.37e-05	0.000219	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPC3—kidney cancer	1.37e-05	0.000219	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SCARB1—kidney cancer	1.37e-05	0.000218	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.36e-05	0.000217	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—POMC—kidney cancer	1.36e-05	0.000217	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.36e-05	0.000217	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.36e-05	0.000217	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—BCHE—kidney cancer	1.36e-05	0.000217	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS1—kidney cancer	1.35e-05	0.000216	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.35e-05	0.000215	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.34e-05	0.000214	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CA2—kidney cancer	1.33e-05	0.000213	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTM1—kidney cancer	1.33e-05	0.000213	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—kidney cancer	1.33e-05	0.000212	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.33e-05	0.000212	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PSMD7—kidney cancer	1.33e-05	0.000212	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.31e-05	0.00021	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.31e-05	0.00021	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALAD—kidney cancer	1.3e-05	0.000208	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.29e-05	0.000207	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PGK1—kidney cancer	1.27e-05	0.000203	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC5A3—kidney cancer	1.27e-05	0.000203	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.27e-05	0.000203	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP1A1—kidney cancer	1.26e-05	0.000202	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—BCHE—kidney cancer	1.26e-05	0.000201	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.26e-05	0.000201	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LDHB—kidney cancer	1.25e-05	0.000199	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.25e-05	0.000199	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CA9—kidney cancer	1.24e-05	0.000198	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC5A5—kidney cancer	1.24e-05	0.000198	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.24e-05	0.000198	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CA9—kidney cancer	1.23e-05	0.000197	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.23e-05	0.000197	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.21e-05	0.000194	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.21e-05	0.000193	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.2e-05	0.000192	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC2A1—kidney cancer	1.2e-05	0.000191	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PGK1—kidney cancer	1.19e-05	0.00019	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.19e-05	0.00019	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.19e-05	0.000189	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LDHB—kidney cancer	1.17e-05	0.000186	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTEN—kidney cancer	1.16e-05	0.000185	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.15e-05	0.000184	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.14e-05	0.000183	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.14e-05	0.000182	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.12e-05	0.000179	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—POMC—kidney cancer	1.11e-05	0.000177	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.1e-05	0.000175	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.09e-05	0.000174	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.08e-05	0.000173	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—kidney cancer	1.08e-05	0.000173	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CA9—kidney cancer	1.08e-05	0.000173	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.08e-05	0.000172	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.07e-05	0.000171	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CRABP1—kidney cancer	1.06e-05	0.000169	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000168	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—POMC—kidney cancer	1.04e-05	0.000167	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.02e-05	0.000163	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CA9—kidney cancer	1.01e-05	0.000161	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.01e-05	0.000161	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—kidney cancer	1e-05	0.00016	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTM1—kidney cancer	9.92e-06	0.000158	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.88e-06	0.000158	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ITPR2—kidney cancer	9.82e-06	0.000157	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ITPR2—kidney cancer	9.76e-06	0.000156	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—kidney cancer	9.46e-06	0.000151	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—kidney cancer	9.45e-06	0.000151	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—POMC—kidney cancer	9.42e-06	0.00015	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	9.41e-06	0.00015	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1A1—kidney cancer	9.41e-06	0.00015	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.26e-06	0.000148	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CRABP1—kidney cancer	9.2e-06	0.000147	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—kidney cancer	9.19e-06	0.000147	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.05e-06	0.000145	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9e-06	0.000144	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.96e-06	0.000143	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTT1—kidney cancer	8.95e-06	0.000143	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ACHE—kidney cancer	8.95e-06	0.000143	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ACHE—kidney cancer	8.9e-06	0.000142	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTT1—kidney cancer	8.9e-06	0.000142	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—kidney cancer	8.84e-06	0.000141	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1A1—kidney cancer	8.71e-06	0.000139	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CRABP1—kidney cancer	8.59e-06	0.000137	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ITPR2—kidney cancer	8.55e-06	0.000137	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SCARB1—kidney cancer	8.47e-06	0.000135	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SCARB1—kidney cancer	8.43e-06	0.000135	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS1—kidney cancer	8.39e-06	0.000134	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS1—kidney cancer	8.34e-06	0.000133	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—kidney cancer	8.33e-06	0.000133	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PSMD7—kidney cancer	8.23e-06	0.000131	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—kidney cancer	8.18e-06	0.000131	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PSMD7—kidney cancer	8.18e-06	0.000131	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAF1—kidney cancer	8.15e-06	0.00013	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ITPR2—kidney cancer	7.99e-06	0.000128	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTT1—kidney cancer	7.8e-06	0.000125	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ACHE—kidney cancer	7.8e-06	0.000125	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—BCHE—kidney cancer	7.8e-06	0.000125	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BCHE—kidney cancer	7.75e-06	0.000124	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.73e-06	0.000123	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—kidney cancer	7.71e-06	0.000123	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.7e-06	0.000123	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC5A5—kidney cancer	7.66e-06	0.000122	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—kidney cancer	7.51e-06	0.00012	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.44e-06	0.000119	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC2A1—kidney cancer	7.4e-06	0.000118	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SCARB1—kidney cancer	7.38e-06	0.000118	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.36e-06	0.000118	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS1—kidney cancer	7.31e-06	0.000117	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—kidney cancer	7.31e-06	0.000117	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTT1—kidney cancer	7.29e-06	0.000116	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ACHE—kidney cancer	7.29e-06	0.000116	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—kidney cancer	7.26e-06	0.000116	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.22e-06	0.000115	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.18e-06	0.000115	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PSMD7—kidney cancer	7.17e-06	0.000114	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.05e-06	0.000113	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—POMC—kidney cancer	7.01e-06	0.000112	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SCARB1—kidney cancer	6.9e-06	0.00011	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS1—kidney cancer	6.83e-06	0.000109	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BCHE—kidney cancer	6.79e-06	0.000109	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC5A5—kidney cancer	6.71e-06	0.000107	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PSMD7—kidney cancer	6.69e-06	0.000107	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—kidney cancer	6.67e-06	0.000107	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—kidney cancer	6.55e-06	0.000105	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—POMC—kidney cancer	6.49e-06	0.000104	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A1—kidney cancer	6.48e-06	0.000104	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BCHE—kidney cancer	6.35e-06	0.000101	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.29e-06	0.000101	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.27e-06	0.0001	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.26e-06	0.0001	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—kidney cancer	6.21e-06	9.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—kidney cancer	6.2e-06	9.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.18e-06	9.87e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—kidney cancer	6.17e-06	9.85e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.05e-06	9.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.87e-06	9.38e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK3—kidney cancer	5.87e-06	9.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—kidney cancer	5.87e-06	9.38e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—kidney cancer	5.84e-06	9.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—kidney cancer	5.7e-06	9.11e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—kidney cancer	5.67e-06	9.06e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—kidney cancer	5.59e-06	8.94e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK1—kidney cancer	5.59e-06	8.93e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—kidney cancer	5.44e-06	8.68e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—kidney cancer	5.41e-06	8.63e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.41e-06	8.63e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1A1—kidney cancer	5.37e-06	8.58e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—kidney cancer	5.28e-06	8.43e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—kidney cancer	5.18e-06	8.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.12e-06	8.18e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—kidney cancer	5.12e-06	8.18e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—kidney cancer	5.05e-06	8.07e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—kidney cancer	4.97e-06	7.93e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—kidney cancer	4.88e-06	7.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—kidney cancer	4.85e-06	7.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—kidney cancer	4.78e-06	7.64e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1A1—kidney cancer	4.71e-06	7.52e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—kidney cancer	4.69e-06	7.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—kidney cancer	4.64e-06	7.41e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—kidney cancer	4.62e-06	7.38e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—kidney cancer	4.52e-06	7.22e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.44e-06	7.09e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.42e-06	7.05e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.4e-06	7.03e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—POMC—kidney cancer	4.03e-06	6.44e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—POMC—kidney cancer	4.01e-06	6.4e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.61e-06	5.77e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—POMC—kidney cancer	3.51e-06	5.61e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.44e-06	5.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—POMC—kidney cancer	3.28e-06	5.24e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—kidney cancer	3.21e-06	5.13e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—kidney cancer	3.2e-06	5.11e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—kidney cancer	3.19e-06	5.09e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—kidney cancer	2.8e-06	4.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—kidney cancer	2.8e-06	4.47e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—kidney cancer	2.79e-06	4.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—kidney cancer	2.62e-06	4.18e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—kidney cancer	2.44e-06	3.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—kidney cancer	2.28e-06	3.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.98e-06	3.16e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—kidney cancer	1.97e-06	3.14e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.72e-06	2.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.61e-06	2.57e-05	CbGpPWpGaD
